Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year

2002

Stage

Series A | Alive

Total Raised

$4.1M

Last Raised

$4.1M | 18 yrs ago

About Auxeris Therapeutics

Auxeris Therapeutics, Inc. is engaged in osteoporosis drug development

Auxeris Therapeutics Headquarter Location

4041 Forest Park Avenue

St. Louis, Missouri, 63108,

United States

314-633-1880

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Auxeris Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Auxeris Therapeutics is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.